Screener
Sarepta Therapeutics, Inc. SRPT Income Tax
Income Tax at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other (loss) income, net: | ||||
| Other (expense) income, net | (15,040) | 38,061 | (30,299) | (45,071) |
| (Loss) income before income tax expense (benefit) | (1,749) | 153,638 | 341,425 | (229,880) |
| Income tax expense (benefit) | 3,141 | (43,254) | 15,356 | 20,736 |
| Net (loss) income | $(4,890) | $196,892 | $326,069 | $(250,616) |
| Other comprehensive (loss) income: | ||||
| Unrealized (losses) gains on investments, net of tax | (444) | (85) | (837) | 167 |
| Total other comprehensive (loss) income | (444) | (85) | (837) | 167 |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s income tax?
- Sarepta Therapeutics, Inc. (SRPT) reported income tax of $3.14M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s income tax changed year-over-year?
- Sarepta Therapeutics, Inc.'s income tax increased by 107.3% year-over-year, from -$43.25M to $3.14M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about Sarepta Therapeutics, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude